期刊文献+

慢性肾衰竭血清晚期糖基化终产物水平的变化及意义 被引量:7

Changes and significance of serum advanced glycosylation end products in patients with chronic renal failure
在线阅读 下载PDF
导出
摘要 目的 探讨慢性肾功能衰竭患者血清晚期糖基化终产物(AGEs)水平的变化、意义及高通量血透对AGEs的清除效果。方法 应用竞争性ELISA法检测慢性肾功能衰竭(CRF)患者(非血液透析组及血液透析组)血清AGEs水平,同时测血浆脂质过氧化物丙二醛(MDA)含量及超氧化物歧化酶(SOD)活性。结果 CRF患者无论血液透析与否,血清AGEs均明显高于健康组(P均<0.001),非血液透析与血液透析组AGEs水平无显著性差异(P<0.05),AGEs水平与CRE呈明显正相关(r=0.5974,P<0.01),与血糖无相关性;CRF患者血浆MDA含量明显高于健康组(P均<0.001),SOD活性明显低于健康组(P<0.05)。AGEs与MDA、SOD间无相关性;常规血液透析(CHD)组,透析前后血清AGEs水平无显著性差异(P<0.05),而高通量血液透析(HFHD)组透析后血清AGEs水平明显降低(P<0.001),两组血浆SOD活性均明显升高(P<0.01),MDA含量明显降低(P<0.01)。结论 CRF时,因肾功能受损致AGEs清除障碍,是血清AGEs水平升高的主要原因,同时CRF时氧化应激增强可能也促进了AGEs生成。高通量血液透析可以有效清除血清AGEs,并改善自由基代谢紊乱。 Objective To evaluate the changes and significance of serum advanced glycosylation end products (ACEs)in patients with chronic renal failure (CRF),and the clearance effect of High - Flux HD to AGEs.Methods The serum AGEs in patients with CRF(Hemodialysis group and Non - Hemodialysis group) were measured by using competitive ELISA.The MDA contents and SOD activities in plasma were also examined.Results Whether HD or not,the serum AGEs levels in patients with CRF were significantly higher than those in normal subjects (both P < 0.001).No significant differences were found between the serum AGEs levels in HD group patients and those in NHD group ( P > 0.05) .A significantly positive correlation was found between the serum AGEs levels and serum CRE values ( P < 0.01) ,no correlation was found between the serum AGEs levels and serum GLU values; The plasma SOD activities in CRF patients were significantly lower than those in healthy subjects (in every group: P < 0.05) .The plasma MDA contents in every group were significantly higher than those in healthy subjects (P<0.001).No correlation was found between AGEs and MDA>SOD ( P > 0.05) ; In CHD (Convention HD) group,there was no significantly difference before and after CHD ( P > 0.05) ,while in HFHD(high flux HD) group,the serum AGEs levels significantly decreased after HFHD( P < 0.001) .In both groups,the plasma SOD activities significantly increased and the plasma MDA contents significantly decreased (both P < 0.01).Conclusion In CRF patients,impaired renal function decreased the clearance of AGEs,the impaired renal function could be the most important factor to make AGEs higher.And the strengthened oxidative stress could have accelerated the formation of AGEs.High - flux HD can clear the serum AGEs efficiently,and alleviate the disorders of free radicals metabolism.
出处 《中国血液净化》 2002年第12期7-11,共5页 Chinese Journal of Blood Purification
关键词 晚期糖基化终产物 慢性肾功能衰竭 氧化应激 高通量血液透析 Advanced glycosylation end products Chronic renal failure Oxidative stress High - flux Hemodialysis
  • 相关文献

参考文献14

  • 1[1]R.Dolhofer-Bliesener, Lechner B, Deppisch R, et al. Immunological determination of advanced glycosylation end-products in human blood and urine. Nephrol Dial Transplant, 1995,10:657-664
  • 2[2]Ritz E, Deppisch R, Nawrath P, et al. Toxicity of uraemia-does it come of AGE ? Nephrol Dial Transplant, 1994, 9(1): 1-2
  • 3[3]Friedman EA. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant 1999,14 Suppl 3:1-9
  • 4[4]Schinzel R, Munch G, Heidland A, et al. Advanced glycation end products in end-stage renal disease and their removal. Nephron 2001,87(4):295-303
  • 5[5]Miyata T, Maeda K, Kurokawa K, et al. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dia Transplant, 1997,12: 255-258
  • 6[6]Meng J, Sakata N, Imanaga Y, et al. Evidence for a link between glycoxidation and lipoperoxidation in patients with chronic renal failure. Clin Nephrol 1999,51(5):280-9
  • 7侯芳玉,李才,苗春生,等.抗晚期糖化终产物抗体的制备[J].中国实验诊断学,1998,2(5):262.
  • 8[8]Nashino T, Horyy Y, Shiiki H, et al. Immunochemical detection of advanced glycosylation end-products within the vascular leisions and glomeruli in diabetic nephropathy. Hum Pathol,1995,26:308-313
  • 9胡伟新,唐政.糖基化终末期产物的基础与临床[J].肾脏病与透析肾移植杂志,1995,4(3):245-251. 被引量:5
  • 10[10]Papanastasiou P, Grass L, Rdela H. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int, 1994,46(1):216-222

共引文献4

同被引文献50

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部